• Blood pressure-lowering is even more ben

    From ScienceDaily@1337:3/111 to All on Tue Sep 1 21:30:32 2020
    Blood pressure-lowering is even more beneficial than previously thought


    Date:
    September 1, 2020
    Source:
    European Society of Cardiology
    Summary:
    Blood pressure medication can prevent heart attacks and strokes -
    even in people with normal blood pressure.



    FULL STORY ========================================================================== Blood pressure medication can prevent heart attacks and strokes -- even
    in people with normal blood pressure. That's the finding of late breaking research presented in a Hot Line session today at ESC Congress 2020.


    ========================================================================== "Greater drops in blood pressure with medication lead to greater
    reductions in the risk of heart attacks and strokes," said principal investigator Professor Kazem Rahimi of the University of Oxford,
    UK. "This holds true regardless of the starting blood pressure level,
    in people who previously had a heart attack or stroke, and in people who
    have never had heart disease." "The fact that the relative effects are
    similar for everyone does not mean that everyone should be treated,"
    he added. "This decision will depend on an individual's likelihood of
    suffering cardiovascular disease in the future - - there are a number
    of risk calculators health professionals can use. Other factors to
    consider are the potential for side effects and the cost of treatment."
    There has been controversy about whether pharmacological blood pressure lowering is equally beneficial in people with versus without a prior
    heart attack or stroke, and when blood pressure is below the threshold
    for hypertension (typically 140/90 mmHg). Evidence from previous studies
    has been inconclusive, leading to contradictory treatment recommendations around the world.

    This was the largest -- and most detailed -- study ever conducted to
    examine these questions. The researchers combined data on individuals
    who had participated in a randomised clinical trial and conducted a meta-analysis. The study included 348,854 participants from 48 trials.

    Participants were divided into two groups: those with a prior diagnosis
    of cardiovascular disease and those without. Each group was divided into
    seven subgroups based on systolic blood pressure at study entry (less than
    120, 120- 129, 130-139, 140-149, 150-159, 160-169, 170 and above mmHg).

    Over an average four years of follow-up, each 5 mmHg reduction in systolic blood pressure lowered the relative risk of major cardiovascular events by about 10%. The risks for stroke, ischaemic heart disease, heart failure
    and death from cardiovascular disease were reduced by 13%, 7% and 14%
    and 5%, respectively.

    Neither the presence of cardiovascular disease nor the level of blood
    pressure at study entry modified the effect of treatment.

    Professor Rahimi said: "The decision to prescribe blood pressure
    medication should not be based simply on a prior diagnosis of
    cardiovascular disease or an individual's current blood pressure. Rather,
    blood pressure medication should be viewed as an effective tool for
    reducing cardiovascular risk when an individual's probability of having
    a heart attack or stroke is elevated."

    ========================================================================== Story Source: Materials provided by European_Society_of_Cardiology. Note: Content may be edited for style and length.


    ==========================================================================


    Link to news story: https://www.sciencedaily.com/releases/2020/09/200901094058.htm

    --- up 1 week, 1 day, 6 hours, 50 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)